Improvement of Major Depression is Associated with Increased Erythrocyte DHA

Lipids

Volumn 48, Issue 9, 2013, Pages 863-868

  Meyer, Barbara J ^a   Grenyer, Brin F S ^a   Crowe, Trevor ^a   Owen, Alice J ^a,b   Grigonis Deane, Elizabeth M ^a   Howe, Peter R C ^a,c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

n 3 Fatty acids; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; HIDHA; ICOSAPENTAENOIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; BECK DEPRESSION INVENTORY; BLOOD ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFICACY; ERYTHROCYTE LEVEL; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OUTCOME ASSESSMENT; PATIENT COUNSELING; PSYCHOLOGIST; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

SCOMBRIDAE;

ADOLESCENT; ADULT; AGED; CAPSULES; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT OILS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; TIME FACTORS; TREATMENT OUTCOME; VITAMIN E; VITAMINS; YOUNG ADULT;

EID: 84950170896     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3801-7     Document Type: Article

References (41)

1. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351:1213
2. Cott J, Hibbeln JR (2001) Lack of seasonal mood change in Icelanders. Am J Psychiatry 158:328
3. Silvers KM, Scott KM (2002) Fish consumption and self-reported physical and mental health status. Public Health Nutrition 5:427-431
4. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H (2001) Fish consumption, depression and suicidality in a general population. Arch Gen Psychiatry 58:512-513
5. Nichols PD, Virtue P, Mooney BD, Elliott NG, Yearsley GK (1998) Seafood the good food. CSIRO Australia
6. Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48:149-155
7. Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of Omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315-319
8. Peet M, Horrobin D (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59:913-919
9. Nemets B, Stahl Z, Belmaker RH (2002) Addition of omega-e fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159:477-479
10. Su KP, Huang SY, Chiu CC, Shen WW (2003) Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13:267-271
11. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, Montorfano G, Negroni M, Berra B, Politi P, Rizzo AM (2010) Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double blind, placebo controlled randomized clinical trial. J Am Coll Nutr 29:55-64
12. Mischoulon D, Papakostas GI, Dording CM et al (2009) A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry 70:1636-1644
13. Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72:211-218
14. Anderson GJ, Connor WE, Corliss JD (1990) Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatr Res 27:89-97
15. Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P et al (2007) Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31:1393-1396
16. Diguer L, Barber J, Luborsky L (1993) Three concomitants: personality disorders, psychiatric severity, and outcome of dynamic psychotherapy of major depression. Am J Psychiatry 150:1246-1248
17. Lepage G, Roy GC (1986) Direct esterification of all classes of lipid in a one step reaction. J Lipid Res 27:114-120
18. Sullivan BL, Williams PG, Meyer BJ (2006) Biomarker validation of a new food frequency questionnaire that estimates long-chain omega-3 polyunsaturated fatty acids. Lipids 41:845-850
19. Elkin I, Shea T, Watkins JT, Imber SD, Sotsky SM, Collins JF et al (1989) National institute of mental health treatment of depression collaborative research programme: general effectiveness of treatments. Arch Gen Psychiatry 46:971-982
20. Baylin A, Kim M, Donovan-Palmer A, Siles X, Dougherty L, Tocco P, Campos H (2005) Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 162:373-381
21. Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133:925S-932S
22. Sarri KO, Linardakis M, Tzanakis N, Kafatos AG (2008) Adipose DHA inversely associated with depression as measured by the beck depression inventory. Prostaglandins Leukot Essent Fatty Acids 78:117-122
23. Mamalakis G, Kalogeropoulos N, Andrikopoulos N, Hatzis C, Kromhout D, Moschandreas J, Kafatos A (2006) Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr 60:882-888
24. Omura M, Kobayashi S, Mizukami Y, Mogami K, Todoroki-Ikeda N, Miyake T, Matsuzaki M (2001) Eicosapentaenoic acid (EPA) induces Ca(2 +)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 487:361-366
25. O'Brien JS, Sampson EL (1965) Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 6:544-551
26. Kim H-Y (2007) Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 282:18661-18665
27. Parletta N, Milte CM, Meyer BJ (2013) Nutritional modulation of cognitive function and mental health. J Nutr Biochem 24:725-743
28. Sinn N, Howe PRC (2008) Mental health benefits of omega-3 fatty acids may be mediated by improvements in cerebral vascular function. Biosci Hypothesis 1:103-108
29. da Silva AX, Lavialle F, Gendrot G, Guesnet P, Alessandri J-M, Lavialle M (2002) Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem 81:1328-1337
30. Pifferi F, Roux F, Langelier B, Alessandri J-M, Vancassel S, Jouin M et al (2005) (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr 135:2241-2246
31. Martins JG (2009) EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 28:525-542
32. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, Shariati-Bafghi S-E (2012) Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2012.08.003
33. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe PRC (2011) Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr doi: 10.1017/S0007114511004788
34. Messa P, Londero D, Massarino F, Paganin L, Mioni G, Zattoni F, Cannella G (2000) Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers. Nephrol Dial Transplant 15:1388-1393
35. Pala V, Krogh V, Muti P, Chajes V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F (2001) Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 93:1088-1095
36. James MJ, Ursin VM, Cleland LG (2003) Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 77:1140-1145
37. Felton CV, Stevenson JC, Godsland IF (2004) Erythrocyte-derived measures of membrane lipid composition in healthy men: associations with arachidonic acid at low to moderate but not high insulin sensitivity. Metabolism 53:571-577
38. Arvindaksham M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP (2003) Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Res 62:195-204
39. Hamazaki T, Sawazaki S, Nagao Y, Kuwamori T, Yazawa K, Mizushima Y, Kobayashi M (1998) Docosahexaenoic acid does not affect aggression of normal volunteers under nonstressful conditions. A randomised, placebo-controlled, double-blind study. Lipids 33:663-667
40. Siscovick DS, Raghunathan TE, King I, Weiunmann S, Bovbjerg VE, Kushi L, Cobb LA, Copass MK, Psaty BM, Lemaitre R, Retzlaff B, Knopp RH (2000) Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 71:208-212
41. Harris WS, von Schacky C (2004) he omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39:212-220